Category: Big Pharma
Categories
- Africa
- African Bank
- Alibaba
- ALSI
- America
- American Debt Crisis
- Antibiotic Resistance
- Apple
- Argentina
- asymmetric information
- Austrian Economics
- Banking Scandal
- Banks
- Basic Income
- BATS
- Behavioral Economics
- Big Data
- Big Pharma
- Bitcoin
- Blockchain
- bonuses
- Book Reviews
- Brexit
- BRIC
- BRICS
- Bruno Iksil
- Buffett Rule
- business news
- Capital in the Twenty-First Century
- Capitalism
- CDO
- CDS
- China
- Cities
- City of London Corporation
- Climate Change
- CMO
- Collateralised Debt Obligations
- Collateralised Mortgage Obligations
- Commodities
- Coronavirus
- Corruption
- Credit Rating
- Credit Rating Downgrade
- Cryptocurrency
- cryptoshares
- Davos 2014
- Deflation
- Dodd-Frank
- EBITDA
- Economic Myths
- Economic Theory
- Economics In Real Life
- Economics News
- Emerging Markets
- Eurozone Debt Crisis
- Exchange Rates
- Facebook IPO
- Featured Posts
- Fed Stress Tests
- FinTech
- Fiscal Deficit
- fiscal policy
- Fixed Rate Mortgages
- Flash Crash
- France
- Freddie Mac
- Free Trade
- FTSE-JSE ALSI
- Game Theory
- Glass-Steagal Act
- Gold
- Gold Standard
- Golden Cross
- Goldman Sachs
- Greek CDS Exposure
- Greek Debt Crisis
- High Frequency Trading
- House Flipping
- hyperinflation
- Iceland
- IMF
- Immigration
- Indicators
- Indices
- inflation
- Infographic
- Insider Trading
- Interest Rate
- Interest Rate Parity
- Interest Rate Risk
- Investing in Art
- Investment Strategies
- Investor Diaries
- IPO
- Iran Sanctions
- ISDA auction
- Japan
- Jim Yong Kim
- JP Morgan
- Just An Observation
- Keynesian economics
- Laffer Curve
- Last Investment Frontier
- Leaving the Eurozone
- Liar's Poker
- LIBOR
- LIBOR collusion scandal
- Liquidity Risk
- Listed Property
- Maps
- Market Mechanism
- Marriage
- MBS
- Medical Aid Schemes
- MF Global
- Michael Lewis
- Microcredit
- Minimum Wage
- monetary policy
- Money
- Mortgage-Backed Securities
- Mortgages
- MTN
- Multi-level Marketing
- NASDAQ
- National Debt
- Net Neutrality
- Ngozi Okonjo-Iweala
- Office Politics
- Oil
- Other
- Overpopulation
- p2p lending
- Parastatals
- Penny Stocks
- Personal Finance
- Petrodollar Wars
- Platinum
- Podcast
- Ponzi Scheme
- Poverty
- Prepayments
- Price Controls
- Price Discrimination
- Pyramid Scheme
- Quantitative Easing
- Questions
- Rating Agency
- REITs
- Remittances
- RIM
- Risk On Risk Off
- rollingalpha
- SARB
- Save The Rhino
- Seigniorage
- Short-selling
- Singapore
- Snapchat
- South Africa
- South Africa's Tax System
- Spain
- Statistics
- Story of Money Podcast
- Student Loans
- Subprime Crisis
- Super Tuesday
- Swiss Franc
- tax system
- TGIF
- The Amateur Investor
- The Big Short
- The Reading List
- The Travelling Economist
- Trade Unions
- Uncategorized
- Unemployment
- Unicorns
- Unit Trusts
- US Credit Rating
- US Housing Market
- Variable Rate Mortgages
- Venezuela
- Volatility
- Volker Rule
- Warren Buffett
- Water Crisis
- Wealth Inequality
- World Bank
- Zimbabwe
Big Pharma
I know these things are meant to be inflammatory (pun intended), but there are some good economic reasons to be concerned about the economics of the healthcare industry: Asymmetric Information: there is a gulf of knowledge gap between doctors and patients. Agency Issues: often, the person receiving the treatment is not the person paying for […]
read more